Cleared Special

K030931 - C3 PATIENT MONITOR

K030931 is the FDA 510(k) clearance for C3 PATIENT MONITOR by Analogic Corp.. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Special 510(k) pathway after a 45-day FDA review.

K030931 · Analogic Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
45d
Days
Class 2
Risk

K030931 is an FDA 510(k) clearance for the C3 PATIENT MONITOR. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Analogic Corp. (Peabody, US). The FDA issued a Cleared decision on May 9, 2003 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Analogic Corp. devices

Submission Details

510(k) Number K030931 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2003
Decision Date May 09, 2003
Days to Decision 45 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 125d · This submission: 45d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 300
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K030931.
M3290A INTELLIVUE INFORMATION CENTER SOFTWARE RELEASE E.1
K031403 · Philips Medical Systems, Inc. · May 2003
DATEX-OHMEDA S/5 ANESTHESIA MONITOR WITH L-AN03 AND L-ANE03A SOFTWARE
K030812 · Datex-Ohmeda · May 2003
DINAMAP PRO 1000 MONITOR WITH SUPERSTAT, MODEL 1000
K022834 · Ge Medical Systems Information Technologies · May 2003
EK-PRO ARRHYTHMIA DETECTION ALGORITHM
K031320 · Ge Medical Systems Information Technologies · May 2003
MODIFICATION TO SOLAR 9500 INFORMATION MONITOR
K030575 · Ge Medical Systems Information Technologies · Mar 2003
PHILIPS MP60, MP70 AND MP90 INTELLIVUE PATIENT MONITORS WITH PORTAL TECHNOLOGY AND M3185 OPT C41 WIRELESS BEDSIDE ADAPTR
K030038 · Philips Medical Systems, Inc. · Mar 2003